Glenmark Pharmaceuticals Gets ANDA Approval For Olmesartan Medoxomil Tablets

Glenmark Pharmaceuticals on Friday informed that it has received ANDA approval by the United States Food & Drug Administration (U.S. FDA) for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, as per BSE filing.Glenmark Pharmaceuticals is up 1.4% at Rs 621 per share at 10:00 hours IST on BSE. It hit a high of Rs 628.70 and a low of Rs 611.95 so far. The company’s peers include Lupin, Dr Reddy’s Laboratories and Sun Pharmaceuticals.

On the NSE, the traded volume of shares of the company is 3,11,395and the traded value is Rs 1935.76 lakhs. The free float market capitalisation is Rs 9323.57 crore.Glenmark Pharmaceuticals Limited is a global pharmaceutical company. It is engaged in the development of new chemical entities and new biological entities.

Glenmark Pharmaceuticals Ltd is currently trading at Rs 620.75, up by Rs 8.8 or 1.44% from its previous closing of Rs 611.95 on the BSE.The scrip opened at Rs 615 and has touched a high and low of Rs 628.7 and Rs 611.95 respectively. So far 603632(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 17269.84 crore.
For Quick Trial – 8962000225 ✔
or mail us here:
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 

Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.